These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 31827270)

  • 21. Diabetic retinopathy screening and management in India: Challenges and possible solutions.
    Kumar A; Agarwal D; Kumar A
    Indian J Ophthalmol; 2021 Mar; 69(3):479-481. PubMed ID: 33595458
    [No Abstract]   [Full Text] [Related]  

  • 22. Capacity building for diabetic retinopathy screening by optometrists in India.
    Ramasamy K; Mishra C
    Indian J Ophthalmol; 2021 Mar; 69(3):482. PubMed ID: 33595459
    [No Abstract]   [Full Text] [Related]  

  • 23. Commentary: A health policy change would benefit a protocol-based screening for diabetic retinopathy in India.
    Das T; Murthy GVS
    Indian J Ophthalmol; 2021 Mar; 69(3):689-690. PubMed ID: 33595501
    [No Abstract]   [Full Text] [Related]  

  • 24. Autonomous Artificial Intelligence in Diabetic Retinopathy: From Algorithm to Clinical Application.
    Channa R; Wolf R; Abramoff MD
    J Diabetes Sci Technol; 2021 May; 15(3):695-698. PubMed ID: 32126819
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Artificial intelligence for diabetic retinopathy.
    Li S; Zhao R; Zou H
    Chin Med J (Engl); 2021 Dec; 135(3):253-260. PubMed ID: 34995039
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Commentary: Training optometrists and allied ophthalmic personnel: Expanding horizon of diabetic retinopathy screening in India.
    Agarwal D; Kumar A; Kumar A
    Indian J Ophthalmol; 2021 Mar; 69(3):659-660. PubMed ID: 33595496
    [No Abstract]   [Full Text] [Related]  

  • 27. Development and Validation of an Automated Diabetic Retinopathy Screening Tool for Primary Care Setting.
    Bhuiyan A; Govindaiah A; Deobhakta A; Gupta M; Rosen R; Saleem S; Smith RT
    Diabetes Care; 2020 Oct; 43(10):e147-e148. PubMed ID: 32855159
    [No Abstract]   [Full Text] [Related]  

  • 28. Diabetic retinopathy screening model for rural population: awareness and screening methodology.
    Rani PK; Raman R; Agarwal S; Paul PG; Uthra S; Margabandhu G; Senthilkumar D; Kumaramanickavel G; Sharma T
    Rural Remote Health; 2005; 5(4):350. PubMed ID: 16212469
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Artificial Intelligence With Deep Learning Technology Looks Into Diabetic Retinopathy Screening.
    Wong TY; Bressler NM
    JAMA; 2016 Dec; 316(22):2366-2367. PubMed ID: 27898977
    [No Abstract]   [Full Text] [Related]  

  • 30. Commentary: Targeted high-risk screening for diabetic retinopathy in India: Feasible short-term strategy.
    Agarwal D; Kumar A; Kumar A
    Indian J Ophthalmol; 2021 Nov; 69(11):3165. PubMed ID: 34708763
    [No Abstract]   [Full Text] [Related]  

  • 31. Strategies to Tackle the Global Burden of Diabetic Retinopathy: From Epidemiology to Artificial Intelligence.
    Wong TY; Sabanayagam C
    Ophthalmologica; 2020; 243(1):9-20. PubMed ID: 31408872
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Artificial intelligence in diabetic retinopathy.
    Williamson TH
    Eye (Lond); 2021 Feb; 35(2):684. PubMed ID: 32291403
    [No Abstract]   [Full Text] [Related]  

  • 33. Artificial intelligence-based screening for diabetic retinopathy at community hospital.
    He J; Cao T; Xu F; Wang S; Tao H; Wu T; Sun L; Chen J
    Eye (Lond); 2020 Mar; 34(3):572-576. PubMed ID: 31455902
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Validation of Deep Convolutional Neural Network-based algorithm for detection of diabetic retinopathy - Artificial intelligence versus clinician for screening.
    Shah P; Mishra DK; Shanmugam MP; Doshi B; Jayaraj H; Ramanjulu R
    Indian J Ophthalmol; 2020 Feb; 68(2):398-405. PubMed ID: 31957737
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Economic Challenges of Artificial Intelligence Adoption for Diabetic Retinopathy.
    Chen EM; Chen D; Chilakamarri P; Lopez R; Parikh R
    Ophthalmology; 2021 Mar; 128(3):475-477. PubMed ID: 32717340
    [No Abstract]   [Full Text] [Related]  

  • 36. Commentary: Understanding diabetic retinopathy trends in India: Lessons learnt and future implications.
    Agarwal D; Kumar A; Kumar A
    Indian J Ophthalmol; 2021 Nov; 69(11):3101-3102. PubMed ID: 34708749
    [No Abstract]   [Full Text] [Related]  

  • 37. The ORNATE India Project: United Kingdom-India Research Collaboration to tackle visual impairment due to diabetic retinopathy.
    Sivaprasad S; Raman R; Conroy D; Mohan ; Wittenberg R; Rajalakshmi R; Majeed A; Krishnakumar S; Prevost T; Parameswaran S; Turowski P; Maheswari U; Khobragade R; Netuveli G; Sadanandan R; Greenwood J; Ramasamy K; Rao M; Bergeles C; Das T;
    Eye (Lond); 2020 Jul; 34(7):1279-1286. PubMed ID: 32398841
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Patient and provider perspectives on barriers to screening for diabetic retinopathy: an exploratory study from southern India.
    Kumar S; Kumar G; Velu S; Pardhan S; Sivaprasad S; Ruamviboonsuk P; Raman R
    BMJ Open; 2020 Dec; 10(12):e037277. PubMed ID: 33303431
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Value of Automated Diabetic Retinopathy Screening with the EyeArt System: A Study of More Than 100,000 Consecutive Encounters from People with Diabetes.
    Bhaskaranand M; Ramachandra C; Bhat S; Cuadros J; Nittala MG; Sadda SR; Solanki K
    Diabetes Technol Ther; 2019 Nov; 21(11):635-643. PubMed ID: 31335200
    [No Abstract]   [Full Text] [Related]  

  • 40. Progress of artificial intelligence in diabetic retinopathy screening.
    Wang YL; Yang JY; Yang JY; Zhao XY; Chen YX; Yu WH
    Diabetes Metab Res Rev; 2021 Jul; 37(5):e3414. PubMed ID: 33010796
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.